Hypothalamus-pituitary-adrenal axis in patients with post-traumatic stress disorders and related to oxidative stress
Author:
Al-Kufaishi Ali M.A.1, Al-Musawi Noor J.T.2
Affiliation:
1. Department of Medical Laboratory Techniques , Al-Furat Al-Awsat Technical University/College of Health and Medical Techniques , Kufa , Iraq 2. University of Babylon/DNA Research Center , Babylon , Iraq
Abstract
Abstract
Objectives
The study involves the effect of hypothalamus-pituitary-adrenal hormones disorders, and related to oxidative stress in individuals with PTSD to those in the healthy group after they experience a specific event that results in a congenital illness or limb loss.
Methods
Obtaining serum samples from males exclusively in cases where psychiatrists have determined that the men have experienced psychological damage brought on by a particular tragedy, and testing the men for hypothalamus-pituitary-adrenal axis and oxidative stress parameters in comparison to healthy participants.
Results
It was observed that there was a notable rise in cortisol levels (5.60 ± 0.93) at 4 pm compared with healthy control (3.43 ± 0.64) resulting from the stimulating effect of the pituitary gland, and this increase has a role in raising levels of oxidative stress in patients total oxidant status (1.08 ± 0.13) compared with control (0.70 ± 0.10). High oxidative stress may lead to increased prolactin levels and decreased testosterone levels.
Conclusions
Transmission of incorrect chemical signals from the central nervous system has a role in causing disturbances in hormonal levels of the hypothalamus and its associated glands, and thus an imbalance in the metabolic rate due to high cortisol. Also, high levels of prolactin hormones play a role in a significant decrease in testosterone levels.
Publisher
Walter de Gruyter GmbH
Reference49 articles.
1. Sultana, E, Shastry, N, Kasarla, R, Hardy, J, Collado, F, Aenlle, K, et al.. Disentangling the effects of PTSD from Gulf War illness in male veterans via a systems-wide analysis of immune cell, cytokine, and symptom measures. Mil Med Res 2024;11:2. https://doi.org/10.1186/s40779-023-00505-4. 2. Burback, L, Brult-Phillips, S, Nijdam, MJ, McFarlane, A, Vermetten, E. Treatment of post-traumatic stress disorder: a state-of-the-art review. Curr Neuropharmacol 2024;22:557–635. https://doi.org/10.2174/1570159x21666230428091433. 3. Horsch, A, Garthus-Niegel, S, Ayers, S, Chandra, P, Hartmann, K, Vaisbuch, E, et al.. Childbirth-related post-traumatic stress disorder: definition, risk factors, pathophysiology, diagnosis, prevention, and treatment. Am J Obstet Gynecol 2024;230:1116–27. https://doi.org/10.1016/j.ajog.2023.09.089. 4. Chambers, R, Gibson, M, Chaffin, S, Takagi, T, Nguyen, N, Mears-Clark, T. Trauma-coerced attachment and complex PTSD: informed care for survivors of human trafficking. J Hum Traffick 2024;10:41–50. https://doi.org/10.1080/23322705.2021.2012386. 5. Murray, SL, Holton, KF. Effects of a diet low in excitotoxins on PTSD symptoms and related biomarkers. Nutr Neurosci 2024;27:1–11. https://doi.org/10.1080/1028415x.2022.2152932.
|
|